Effectiveness and Safety of Ruxolitinib for the Treatment of Refractory Systemic Idiopathic Juvenile Arthritis Like Associated With Interstitial Lung Disease : A Case Report
Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2020-216983
Full Text
Open PDFAbstract
Available in full text
Date
February 13, 2020
Authors
Publisher
BMJ